Prosecution Insights
Last updated: May 29, 2026
Application No. 17/976,352

Method of Selecting Solvent for Polymer and Composition Containing Selected Solvent

Final Rejection §102§103
Filed
Oct 28, 2022
Priority
Oct 30, 2021 — RE 10-2021-0147492
Examiner
NERANGIS, VICKEY M
Art Unit
1763
Tech Center
1700 — Chemical & Materials Engineering
Assignee
SK Ie Technology Co. Ltd.
OA Round
2 (Final)
56%
Grant Probability
Moderate
3-4
OA Rounds
0m
Est. Remaining
85%
With Interview

Examiner Intelligence

Grants 56% of resolved cases
56%
Career Allowance Rate
654 granted / 1161 resolved
-8.7% vs TC avg
Strong +29% interview lift
Without
With
+28.9%
Interview Lift
resolved cases with interview
Typical timeline
3y 2m
Avg Prosecution
51 currently pending
Career history
1222
Total Applications
across all art units

Statute-Specific Performance

§101
0.2%
-39.8% vs TC avg
§103
81.1%
+41.1% vs TC avg
§102
5.3%
-34.7% vs TC avg
§112
3.3%
-36.7% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1161 resolved cases

Office Action

§102 §103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Response to Amendment All outstanding rejections, except for those maintained below, are withdrawn in light of applicant’s amendment filed on 8/8/2025. The text of those sections of Title 35, U.S. Code not included in this action can be found in a prior office action. The new grounds of rejection set forth below are necessitated by applicant’s amendment filed on 8/8/2025. In particular, claims 1 and 3 have been amended to exclude DMAc, and claims 13-20 are new. Thus, the following action is properly made final. Claim Rejections - 35 USC § 102 Claims 1-4, 6, 7, 9, and 13-20 are rejected under 35 U.S.C. 102(a)(2) as being anticipated by Yun (US 2020/0095376). With respect to claims 1, 2, and 13-17, Yun discloses polymerizing polyimide for use in a polyimide-based film having excellent transparency (paragraph 0053) from a polyimide precursor and amide-based organic solvent (abstract). Example 1 is prepared by polymerizing DMPA (dimethylpropionamide (paragraph 0100), 2,2’-bis(trifluoromethyl)-4,4’-biphenyl and pyromellitic dianhydride (paragraph 0106). While Yun does not explicitly disclose the claimed conditions (1) to (4), the exemplified polymerization solvent DMPA inherently meets the claimed properties given that Applicant has disclosed in the specification as originally filed that DMPA meets claimed conditions (1) to (4) (page 27, Table 2). Therefore, the step in the claimed method of “selecting” a polymerization solvent having conditions (1) to (4) is inherently met by an example in Yun using DMPA. With respect to claims 3, 4, 6, and 18-20, Yun discloses polymerizing polyimide for use in a polyimide-based film having excellent transparency (paragraph 0053) from a polyimide precursor and amide-based organic solvent (abstract). Example 1 is prepared by polymerizing DMPA (dimethylpropionamide (paragraph 0100), 2,2’-bis(trifluoromethyl)-4,4’-biphenyl diamine (aromatic diamine) and pyromellitic dianhydride (paragraph 0106). While Yun does not explicitly disclose the claimed conditions (1) to (4), the exemplified polymerization solvent DMPA inherently meets the claimed properties given that Applicant has disclosed in the specification as originally filed that DMPA meets claimed conditions (1) to (4) (page 27, Table 2). With respect to claim 7, 2,2’-bis(trifluoromethyl)-4,4’-biphenyl diamine is the same as 2,2-bis(trifluoromethyl)benzidine. With respect to claim 9, Yan does not disclose aromatic diacid dichlorides. Even so, this claim further limits an alternative structural unit does not exclude the alternative embodiment of aromatic diamine or dianhydride. Since the latter embodiments are disclosed by Yan as discussed above, it is proper to include this claim in this rejection. Claim Rejections - 35 USC § 103 Claims 1-9 and 13-20 are rejected under 35 U.S.C. 103 as being unpatentable over Park (US 10,370,496) in view of Yun (US 2020/0095376). With respect to claims 1, 2, and 13-17 Park discloses a polyamic acid composition for making a polyamideimide film thereof (abstract) having excellent light transmittance (col. 18, lines 53-58). Park teaches that the solvent is not particularly limits and includes dimethylacetamide (DMAc) (col. 5, lines 44-52). For example, Park’s Example 1 is a composition comprising DMAc as polymerization solvent and polymerizable units 2,2’-bis(trifluoromethyl)benzidine (aromatic diamine), 4,4’-hexafluoroisopropylidene diphthalic anhydride (aromatic dianhydride) cyclobutene tetracarboxylic dianhydride (aliphatic dianhydride), and isophthaloyl dichloride (aromatic diacid dichloride) (col. 10, lines 28-44). Park discloses that polar solvents are preferred such as exemplified DMAc but fails to disclose a solvent meeting claimed conditions (1) to (4). Yun discloses polymerizing polyimide for use in a polyimide-based film having excellent transparency (paragraph 0053) from a polyimide precursor and amide-based organic solvent (abstract). Yun teaches that the amide-based organic solvent such as dimethylpropionamide (DMPA) alleviates the interaction between polyamic acid (polyimide precursor) and polymerization solvent to reduce viscosity of the polyimide precursor solution allowing for a high solids content (paragraph 0039). Example 1 is prepared by polymerizing dimethylpropionamide (DMPA) (paragraph 0100), 2,2’-bis(trifluoromethyl)-4,4’-biphenyl (TFMB) and pyromellitic dianhydride (paragraph 0106, Table 2). Comparative Example 1 is like Example 1 except that the solvent is DMAc and has a polyimide precursor solution viscosity that is twice as much as Example 1 (Table 1). While Yun does not explicitly disclose the claimed conditions (1) to (4), the exemplified polymerization solvent DMPA inherently meets the claimed properties given that Applicant has disclosed in the specification as originally filed that DMPA meets claimed conditions (1) to (4) (page 27, Table 2). Given that both Park and Yun are drawn to solutions containing polyamic acids and further given that Yun teaches that DMPA is advantageously used as the solvent compared to DMAc taught exemplified by Park, it would have been obvious to one of ordinary skill in the art to select DMPA as the solvent in polyamic acid polymerizable solutions of Park and thereby necessarily also “select” a polymerization solvent having claimed conditions (1) to (4). With respect to claims 3-9 and 18-20, Park discloses a polyamic acid composition for making a polyamideimide film thereof (abstract) having excellent light transmittance (col. 18, lines 53-58). Park teaches that the solvent is not particularly limits and includes dimethylacetamide (DMAc) (col. 5, lines 44-52). For example, Park’s Example 1 is a composition comprising DMAc as polymerization solvent and polymerizable units 2,2’-bis(trifluoromethyl)benzidine (aromatic diamine), 4,4’-hexafluoroisopropylidene diphthalic anhydride (aromatic dianhydride) cyclobutene tetracarboxylic dianhydride (aliphatic dianhydride), and isophthaloyl dichloride (aromatic diacid dichloride) (col. 10, lines 28-44). Park discloses that polar solvents are preferred such as exemplified DMAc but fails to disclose a solvent meeting claimed conditions (1) to (4). Yun discloses polymerizing polyimide for use in a polyimide-based film having excellent transparency (paragraph 0053) from a polyimide precursor and amide-based organic solvent (abstract). Yun teaches that the amide-based organic solvent such as dimethylpropionamide (DMPA) alleviates the interaction between polyamic acid (polyimide precursor) and polymerization solvent to reduce viscosity of the polyimide precursor solution allowing for a high solids content (paragraph 0039). Example 1 is prepared by polymerizing dimethylpropionamide (DMPA) (paragraph 0100), 2,2’-bis(trifluoromethyl)-4,4’-biphenyl (TFMB) and pyromellitic dianhydride (paragraph 0106, Table 2). Comparative Example 1 is like Example 1 except that the solvent is DMAc and has a polyimide precursor solution viscosity that is twice as much as Example 1 (Table 1). While Yun does not explicitly disclose the claimed conditions (1) to (4), the exemplified polymerization solvent DMPA inherently meets the claimed properties given that Applicant has disclosed in the specification as originally filed that DMPA meets claimed conditions (1) to (4) (page 27, Table 2). Given that both Park and Yun are drawn to solutions containing polyamic acids and further given that Yun teaches that DMPA is advantageously used as the solvent compared to DMAc taught exemplified by Park, it would have been obvious to one of ordinary skill in the art to select DMPA as the solvent in polyamic acid polymerizable solutions of Park. Response to Arguments Applicant's arguments filed 8/8/2025 have been fully considered but they are moot in view of the new grounds of rejection set forth above. Conclusion Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to VICKEY NERANGIS whose telephone number is (571)272-2701. The examiner can normally be reached 8:30 am - 5:00 pm EST, Monday - Friday. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Joseph Del Sole can be reached at (571)272-1130. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /VICKEY NERANGIS/Primary Examiner, Art Unit 1763 vn
Read full office action

Prosecution Timeline

Oct 28, 2022
Application Filed
May 19, 2025
Non-Final Rejection mailed — §102, §103
Aug 08, 2025
Response Filed
Sep 18, 2025
Final Rejection mailed — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12637567
STYRENE-BASED RESIN COMPOSITION
4y 5m to grant Granted May 26, 2026
Patent 12630736
NOVEL NANOEMULSIONS, METHODS OF THEIR PRODUCTION AND RELATED USES AND PRODUCTS
4y 7m to grant Granted May 19, 2026
Patent 12617945
THERMOPLASTIC COMPOSITION
5y 7m to grant Granted May 05, 2026
Patent 12617950
POLYMER PARTICLES COMPRISING LIGNIN AND RELATED ADDITIVE MANUFACTURING METHODS
4y 6m to grant Granted May 05, 2026
Patent 12606672
CURABLE COMPOSITION
3y 10m to grant Granted Apr 21, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
56%
Grant Probability
85%
With Interview (+28.9%)
3y 2m (~0m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 1161 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month